2016
DOI: 10.1016/j.jvs.2016.02.053
|View full text |Cite
|
Sign up to set email alerts
|

Migration of the Nellix endoprosthesis

Abstract: PURPOSE: To report the incidence and sequelae of migration of the Nellix® endoprothesis following endovascular aneurysm sealing (EVAS).METHOD: A review was performed of the follow-up imaging of all EVAS patients in a University Hospital endovascular programme who had a minimum follow-up of one year. Using the first post-operative and latest follow-up CT scans, the distances between the proximal and distal borders of the stent-grafts relative to reference vessels were measured using a previously validated techn… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

1
37
0

Year Published

2016
2016
2019
2019

Publication Types

Select...
10

Relationship

1
9

Authors

Journals

citations
Cited by 53 publications
(38 citation statements)
references
References 13 publications
1
37
0
Order By: Relevance
“…Proximal migration of the Nellix endoprosthesis has been reported to occur in 17 % of cases [6]. In our case, a small type Ia endoleak was initially identifi ed on the 1-month surveillance CT. After discussion at our MDT meeting, we decided to deviate from our local surveillance protocol to closely monitor the endoleak.…”
Section: Discussionmentioning
confidence: 66%
“…Proximal migration of the Nellix endoprosthesis has been reported to occur in 17 % of cases [6]. In our case, a small type Ia endoleak was initially identifi ed on the 1-month surveillance CT. After discussion at our MDT meeting, we decided to deviate from our local surveillance protocol to closely monitor the endoleak.…”
Section: Discussionmentioning
confidence: 66%
“…The incidence of migration is largely unknown, although a > 4 mm displacement was described in five of 18 EVAS treated patients. 13 At 1 year, core laboratory adjudicated migration >10 mm occurred in three patients (2.3%) in the Nellix system IDE pivotal trial. 9 Migration was not reported in the 12 month outcome of the EVAS FOR-WARD Global Registry, 10 but this was only site reported.…”
Section: Discussionmentioning
confidence: 99%
“…While there is limited knowledge of factors that lead to poor outcomes following ChEVAS, in our cohort the majority of the 56 technically feasible EVAS cases were judged to be outside the current infrarenal IFU 20 regarding thrombus diameters, which have been recently updated owing to the risk for migration. 21 This represents a recent development in EVAS knowledge and is a reminder that technical applicability should not be conflated with clinical appropriateness.…”
Section: Discussionmentioning
confidence: 96%